抗生素
抗生素耐药性
致病菌
抗药性
重症监护医学
人类健康
医学
全球卫生
公共卫生
微生物学
生物技术
细菌
生物
环境卫生
遗传学
护理部
作者
Mathieu F. Chellat,Luka Raguž,Rainer Riedl
标识
DOI:10.1002/anie.201506818
摘要
Abstract Finding strategies against the development of antibiotic resistance is a major global challenge for the life sciences community and for public health. The past decades have seen a dramatic worldwide increase in human‐pathogenic bacteria that are resistant to one or multiple antibiotics. More and more infections caused by resistant microorganisms fail to respond to conventional treatment, and in some cases, even last‐resort antibiotics have lost their power. In addition, industry pipelines for the development of novel antibiotics have run dry over the past decades. A recent world health day by the World Health Organization titled “Combat drug resistance: no action today means no cure tomorrow” triggered an increase in research activity, and several promising strategies have been developed to restore treatment options against infections by resistant bacterial pathogens.
科研通智能强力驱动
Strongly Powered by AbleSci AI